Conclusions In patients with raised ICP due to IIH, exenatide, a drug emerging as an ICP lowering agent, does not adversely impact cognition
Many of the same drugs are also prescribed for weight loss, with different formulations and doses approved for each use
Substantial weight gain is also a common side effect of many mood-altering drugs (psychotropics), which include antidepressants and antipsychotics, especially for individuals with severe mental illnesses like schizophrenia and major depressive disorder who must take their medications indefinitely to reduce the risk of symptom relapse
Studied doses typically range from 900 to 1,500 mg daily, divided into two or three doses to minimize gastrointestinal side effects, though it's important to note that berberine has poor and variable oral bioavailability
Semaglutide GLP-1 for weight loss works to manage appetite and blood sugar levels